The current study demonstrates a physicochemical function of phase-separated BRD4 to limit DSBs upon either oxidative stress or irradiation; and that pharmaceutical degradation of BRD4 significantly reduced the clonogenic growth potential of irradiated cancer cells. Here, BRD4 is linked to cancer.